SCYNEXIS announces positive results from first interim efficacy analysis of FURI study

on
SCYNEXIS, Inc., a biotechnology company delivering innovative therapies for difficult-to-treat and often life-threatening infections, today announced positive results from the first interim efficacy analysis of the ongoing FURI study.

from The Medical News http://bit.ly/2BefhXz

Comments

Post a Comment

diet weight loss

diet weight loss

diet weight loss

Legal Notice: Product prices and availability are subject to change. Visit corresponding website for more details. Trade marks & images are copyrighted by their respective owners.

helth

health

health

Legal Notice: Product prices and availability are subject to change. Visit corresponding website for more details. Trade marks & images are copyrighted by their respective owners.